Botanix Pharmaceuticals (ASX:BOT) Accounts Payable : A$2.20 Mil (As of Dec. 2023)

View and export this data going back to 1985. Start your Free Trial

What is Botanix Pharmaceuticals Accounts Payable?

Botanix Pharmaceuticals's Accounts Payable for the quarter that ended in Dec. 2023 was A$2.20 Mil.

Botanix Pharmaceuticals's quarterly Accounts Payable declined from Dec. 2022 (A$3.88 Mil) to Jun. 2023 (A$1.39 Mil) but then increased from Jun. 2023 (A$1.39 Mil) to Dec. 2023 (A$2.20 Mil).

Botanix Pharmaceuticals's annual Accounts Payable increased from Jun. 2021 (A$0.65 Mil) to Jun. 2022 (A$4.68 Mil) but then declined from Jun. 2022 (A$4.68 Mil) to Jun. 2023 (A$1.39 Mil).

Botanix Pharmaceuticals Accounts Payable Historical Data

The historical data trend for Botanix Pharmaceuticals's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Botanix Pharmaceuticals Accounts Payable Chart

Botanix Pharmaceuticals Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Accounts Payable

Get a 7-Day Free Trial

4.12

1.01

0.65

4.68

1.39

Botanix Pharmaceuticals Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Accounts Payable	Get a 7-Day Free Trial															2.65	4.68	3.88	1.39	2.20

Botanix Pharmaceuticals Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Botanix Pharmaceuticals Accounts Payable Related Terms

Thank you for viewing the detailed overview of Botanix Pharmaceuticals's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Botanix Pharmaceuticals (ASX:BOT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Botanix Pharmaceuticals Ltd (ASX:BOT) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

BXPHF:USA

Address

661 Newcastle Street, D2, LEEDERVILLE, WA, AUS, 6007

Website

https://www.botanixpharma.com

Botanix Pharmaceuticals Ltd is a clinical-stage cannabinoid therapeutics company. The company's focus is the development of safe and effective topical treatments for serious skin conditions. It has an exclusive license to use a proprietary drug delivery system - Permetrex for direct skin delivery of active pharmaceuticals in all skin diseases. The company's product pipeline includes BTX1503 - Moderate to Severe Acne, BTX1308 - Plaque Psoriasis, BTX1204 - Atopic Dermatitis, and BTX 1701 - Mild Acne. The majority of Revenue is Derived from Australia.

Botanix Pharmaceuticals (ASX:BOT) Headlines

No Headlines